Rational Design, Synthesis and Biological Evaluation of Pyrimidine-4,6-diamine derivatives as Type-II inhibitors of FLT3 Selective Against c-KIT.
Rational Design, Synthesis and Biological Evaluation of Pyrimidine-4,6-diamine derivatives as Type-II inhibitors of FLT3 Selective Against c-KIT.
复制标题
DOI:
10.1038/s41598-018-21839-3
复制
发表时间:
2018-02-27
影响因子:
4.6
通讯作者:
Li HY
中科院分区:
文献类型:
--
作者:
Bharate JB;McConnell N;Naresh G;Zhang L;Lakkaniga NR;Ding L;Shah NP;Frett B;Li HY
FMS-like Tyrosine Kinase 3 (FLT3) is a clinically validated target for acute myeloid leukemia (AML). Inhibitors targeting FLT3 have been evaluated in clinical studies and have exhibited potential to treat FLT3-driven AML. A frequent, clinical limitation is FLT3 selectivity, as concomitant inhibition of FLT3 and c-KIT is thought to cause dose-limiting myelosuppression. Through a rational design approach, novel FLT3 inhibitors were synthesized employing a pyridine/pyrimidine warhead. The most potent compound identified from the studies is compound 13a, which exhibited an IC50 value of 13.9 ± 6.5 nM against the FLT3 kinase with high selectivity over c-KIT. Mechanism of action studies suggested that 13a is a Type-II kinase inhibitor, which was also supported through computer aided drug discovery (CADD) efforts. Cell-based assays identified that 13a was potent on a variety of FLT3-driven cell lines with clinical relevance. We report herein the discovery and therapeutic evaluation of 4,6-diamino pyrimidine-based Type-II FLT3 inhibitors, which can serve as a FLT3-selective scaffold for further clinical development.
登录
查看更多内容
影响因子:
--
作者:
Frett, Brendan;McConnell, Nick;Li, Hong-yu
通讯作者:
Li, Hong-yu
影响因子:
6.7
作者:
Kim, Hyuntae;Lee, Chulho;Han, Gyoonhee
通讯作者:
Han, Gyoonhee
影响因子:
3
作者:
Trott, Oleg;Olson, Arthur J.
通讯作者:
Olson, Arthur J.
影响因子:
11.5
作者:
Cooper, Todd M.;Cassar, Jeannette;Brown, Patrick A.
通讯作者:
Brown, Patrick A.
影响因子:
5
作者:
Mashkani, Baratali;Tanipour, Mohammad Hossein;Griffith, Renate
通讯作者:
Griffith, Renate